Navigation Links
Significant Barriers Prevent People with MS from Fully Committing to Treatment Regimen, New Survey Reveals
Date:5/28/2008

g on treatment had to do with affording her medicine, a barrier also noted by 27 percent of people surveyed.(1) "The day I learned I had MS, I vowed to do everything I could to fight the disease. So when my doctor recommended treatment, I followed his advice," Jillian said. "But my commitment was challenged when I recently lost my insurance. With only three doses of my medication left and no possible way to pay for another prescription, I was going to lose the one thing that was going well for me. My doctor told me that I could continue receiving my medicine through a company-sponsored patient assistance program. It's one of the benefits of the BETAPLUS(TM)(b) program that patients on Betaseron can sign up for. It was a great relief and allowed me to continue my fight against the disease."

Participants in the survey noted that worries about how to store medicine while traveling or away from home (9 percent) also diminish their commitment to treatment. Factors cited by survey participants that make it easier to stay on medication include family support (84 percent), drug company-sponsored support such as materials or Web sites (60 percent) and a nurse provided by a drug company (43 percent).(1)

The survey was conducted by Russell Research and funded by Bayer HealthCare Pharmaceuticals Inc.(1)

About Betaseron

Betaseron (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

A number of factors have been shown to influence a person's perceived comfort and satisfaction associated with MS medications, including number of injections, product formulation and patient support. Betaseron therapy requires half as many injections as Copaxone(R)* (glatiramir acetate).(
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Study presented at DDW 2008 Confirms that New Device Significantly Improves Detection of Polyps in the Colon
2. Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD
3. Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD
4. Study: Doctors Significantly Less Likely to Provide Women with Treatments to Prevent Heart Attacks
5. Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
6. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
7. Paramed Systems Achieves Significant Business Milestone in the Offshore Oil and Gas Evacuation Market
8. Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture
9. U.S. Patent Office Allows Another Significant VNUS Patent
10. Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms
11. Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural body ... new natural sunscreen. They are offering the sunscreen in ... come with a bonus lip balm sunscreen. , The new ... Click to see the natural sunscreen on Amazon . ... made with non-nano zinc oxide and provides broad-based protection against ...
(Date:3/28/2015)... With more than 4,500 scientists, clinicians and ... and musculoskeletal diseases gathered here for the World ... time in the 17-year history of the field’s ... is an emerging non-pharmaceutical protocol for enhancing bone ... Wolff’s law, osteogenic loading at multiples of body ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 An article ... problem which could prove critical to organizations that deal ... a critical aspect of data security, is worsening . ... data security report, every major category out of the ... penetration testing. “With all the craziness that has gone ...
(Date:3/28/2015)... 28, 2015 Delaying rotator cuff surgery ... according to research presented today at the American Orthopaedic ... , “Our study compared results for 170 patients who ... additional glenohumeral joint capsule release procedure to relieve stiffness ... PhD, lead author from St. George Hospital in Sydney, ...
(Date:3/28/2015)... Omaha, NE (PRWEB) March 28, 2015 ... leader in healthcare staffing, including physical therapy jobs, ... exhibitor at the Ohio Physical Therapy Association Annual ... the Renaissance Columbus Downtown Hotel in Columbus, OH. ... programming, networking opportunities, and exhibits with products and ...
Breaking Medicine News(10 mins):Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3Health News:Non-Drug Protocol for Building Bone Density Expected to Steal Spotlight at World Congress on Osteoporosis 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the Ohio Physical Therapy Association Annual Conference 2
... receiving record amounts of money for such efforts , ... for tobacco prevention programs by more than 15 percent ... amounts of money from tobacco taxes and from the ... , "Fully funded tobacco prevention and cessation programs stop ...
... , , LANGHORNE, Pa., ... revolutionized with the introduction of TendoFlex - an innovative, ... motion exercises and abdominal core strengthening, allowing users to ... and aching. TendoFlex lets users stretch ...
... , , , HARROGATE, England, Dec. 9 ... on Polyphenols and Health (ICPH) further demonstrates that Concord grape ... function in certain population groups. The Concord grape has long ... healthy aging, and researchers are now also seeking to understand ...
... , ATLANTA and ... medical transcription service provider in the U.S. and the only leading ... been rated No. 1 in their category for professional services in ... report. A first-time entrant into the annual survey, ...
... , WINNIPEG, Manitoba, Dec. 9 IBM ... with the Government of Manitoba to enhance healthcare throughout the ... system. This technology can offer healthcare providers secure and quick ... and quality of patient care while reducing healthcare costs. ...
... Department of Neurology at Jefferson Medical College (JMC) of Thomas ... the National Institutes of Health (NIH) for the creation of ... science research to its translation into clinical applications. The ... as much as $10 million by the end of award ...
Cached Medicine News:Health News:States Slash Funding for Tobacco Prevention Programs 2Health News:States Slash Funding for Tobacco Prevention Programs 3Health News:All-New TendoFlex(TM) Revolutionizes Stretching and Core Strengthening 2Health News:The Concord Grape Commands Attention at Major Scientific Conference 2Health News:The Concord Grape Commands Attention at Major Scientific Conference 3Health News:The Concord Grape Commands Attention at Major Scientific Conference 4Health News:The Concord Grape Commands Attention at Major Scientific Conference 5Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 2Health News:Webmedx Announces #1 Ranking in KLAS 2009 Transcription Services Report 3Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 2Health News:IBM Chosen to Build System for Electronic Health Records in Manitoba for Improved Patient Care 3
(Date:3/27/2015)... , March 27, 2015   Hospira, Inc. ... in biosimilars and the world,s leading provider of ... that support an evaluation of biosimilarity of its ... and Drug Administration (FDA) conditionally approved name of ... (epoetin alfa). These study data were presented at ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 /PRNewswire/ ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces the reporting ... the Company,s Melphalan Hydrochloride for Injection with the ... therapies in a poster presentation at the Society of ...
(Date:3/26/2015)... March 26, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... a focus on Omega-3 therapies for cardiovascular disease and ... issued 763,752 common shares of the Corporation (the "Common ... the period of December 5 th , 2014 to ... Notes that is due on or before April 1, ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
Medicine Products: